A dynamic molecular glue targets a plastic MDA5 filament interface to stimulate innate immunity
This paper identifies MA2, a small-molecule agonist of MDA5 that enhances antiviral and antitumor immunity by dynamically stabilizing MDA5 filaments.
Author
Dana-Farber Cancer InstituteORCID 0000-0002-2287-5663Unclaimed ORCID profile · follow to get notified of new preprints
5 papers
Recent·Most cited
This paper identifies MA2, a small-molecule agonist of MDA5 that enhances antiviral and antitumor immunity by dynamically stabilizing MDA5 filaments.
Maria Davern, Cole J. Turner, Daryl Griffin…·Anthony G. Letai
This study identifies common survival mechanisms between drug-tolerant persisters and immunotherapy persisters, showing they share reduced mitochondrial apoptotic sensitivity and cross-resistance to therapies.
Koji Haratani, Bruce B. Reinhold, Jonathan S. Duke‐Cohan…·Ellis L. Reinherz
This study identifies that cancers limit p53 neoantigen display on MHC molecules, evading T cell detection through immune selection and ERAP1-mediated destruction.
Olesja Popow, Qing Yu, Clarence Yapp…·Kevin M. Haigis
The paper shows that low baseline c-Myc expression restricts oncogenic K-Ras activity in tissues, and this can be reversed by increasing c-Myc in the liver.
Roni Lehmann‐Werman, Aviad Zick, Cloud Peter Paweletz…·Yuval Dor
The paper identifies methylation patterns specific to intestinal epithelial cells to detect cell-free DNA in plasma, showing increased levels in advanced CRC compared to IBD and PDAC.